Peaks of Interest
Fasha Mahjoor, CEO of Phenomenex (Torrance, California), has been awarded an Ellis Island Medal of Honor.
Phenomenex CEO Fasha Mahjoor Awarded an Ellis Island Medal of Honor
Fasha Mahjoor, CEO of Phenomenex (Torrance, California), has been awarded an Ellis Island Medal of Honor. The awards are given annually by the National Ethnic Coalition of Organizations (NECO) in recognition of leaders who are philanthropic, who preserve and celebrate the values of their ancestry group, and who promote tolerance and acceptance.
More than 10,000 nominations are received each year, and this year 98 were presented at an awards ceremony held in the Great Hall on Ellis Island in New York Harbor. The awards are recognized by the United States House of Representatives and the United States Senate, and are read into the congressional record. Past awardees have included United States presidents and Nobel Prize winners.
Mahjoor was selected by NECO for his dedication to humanitarian efforts globally. The American Red Cross publicly recognized Mahjoor and his companies for their support of Superstorm Sandy disaster relief efforts. He recently abseiled over 1000 feet of the Shard skyscraper (London, UK) to raise funds for The Outward Bound Trust educational charity, and sponsored the making of over 200,000 meals for starving children in developing countries at Phenomenex companies in the United States and Italy.
Malvern Breaks into Grinding and Dispersing Market
Malvern Instruments (Malvern, UK) has entered a three year co-marketing agreement with Netzsch Grinding and Dispersing (Selb, Germany). The two companies serve shared markets including food, ceramics, pharmaceuticals, nano-technology applications, and surface coatings through to metal and mineral mining.
Particle characterization is becoming increasingly important for fine grinding to the submicron- or nanometer range because product properties often depend directly on particle size, according to Dimitrios Makrakis, Netzsch Grinding & Dispersing Business Unit managing director. He added: "The correct and reproducible analysis of particle size is a prerequisite for process optimization and quality control. As Malvern is a world-leading manufacturer in particle and materials characterization, we have the ideal partner to deliver the best overall solution for both grinding technology and particle characterization and clients of both companies will benefit from this partnership."
Under the terms of the agreement, Malvern instrumentation will be installed in Netzsch demonstration and test laboratories in China, Brazil, Germany, Korea, India, and Russia. Customer materials in Netzsch facilities will be routinely tested using Malvern instrumentation, with Malvern staff available for consultation about analyzing data. The companies will work together to organize seminars and other initiatives to target key markets.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
